Great Diamond Partners LLC Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Great Diamond Partners LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 706 shares of the medical equipment provider’s stock after selling 386 shares during the period. Great Diamond Partners LLC’s holdings in Intuitive Surgical were worth $347,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Ullmann Wealth Partners Group LLC boosted its stake in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC lifted its position in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares during the last quarter. Daymark Wealth Partners LLC increased its stake in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after purchasing an additional 24 shares during the period. Indiana Trust & Investment Management CO increased its stake in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after purchasing an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC increased its stake in Intuitive Surgical by 4.9% in the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 53,038 shares of company stock valued at $25,857,344 in the last three months. 0.80% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners raised their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $516.31 on Wednesday. The stock’s 50-day moving average is $489.22 and its two-hundred day moving average is $444.82. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34. The company has a market cap of $183.90 billion, a price-to-earnings ratio of 83.01, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.